Westfield Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$120M Sell
249,299
-610,814
-71% -$162M 0.39% 69
2026
Q1
$94.3M Buy
860,113
+664,819
+340% +$94.7M 0.4% 80
2025
Q4
$32.5M Buy
195,294
+2,680
+1% +$448K 0.14% 170
2025
Q3
$37.7M Buy
+192,614
New +$31.7M 0.16% 171
2025
Q2
Sell
-467,080
Closed -$27.9M 281
2025
Q1
$27.9M Buy
+467,080
New +$43.2M 0.14% 163
2024
Q4
Sell
-993,482
Closed -$52M 278
2024
Q3
$52M Buy
+993,482
New +$46.6M 0.24% 133

Other funds holding ALAB

Westfield Capital Management's ALAB Position: Q2 2026 in Review

Westfield Capital Management reduced its Astera Labs (ALAB) stake by 71% in Q2 2026, selling an estimated $162M and leaving 249,299 shares worth $120M. The position accounts for 0.39% of the portfolio, ranked #69.

Westfield Capital Management first reported a position in ALAB in Q3 2024 and has held it in 6 quarters since. 982 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Westfield Capital Management held 249,299 shares of Astera Labs worth $120M as of Q2 2026.
  • Westfield Capital Management sold 610,814 Astera Labs shares in Q2 2026, an estimated $162M.
  • Astera Labs made up 0.39% of Westfield Capital Management's portfolio in Q2 2026, its #69 holding.
  • Westfield Capital Management first reported a position in Astera Labs in Q3 2024 and has held it in 6 quarters since.
  • 982 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Westfield Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.